Histopathological characterization of inflammatory interparietal involvement in frontal fibrosing alopecia. [PDF]
Front Med (Lausanne)Gonzalez Cañete M +5 more
europepmc +1 more source
Prostate-specific antigen clearance after surgery for benign prostate enlargement in a cohort with median prostate-specific antigen greater than 4ng/ml. [PDF]
BMC UrolNwosu EO +6 more
europepmc +1 more source
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study. [PDF]
Eur Urol Open SciVentimiglia E +7 more
europepmc +1 more source
SRY mediates male-specific susceptibility to acute liver injury. [PDF]
Cell Commun SignalKe MY +9 more
europepmc +1 more source
Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. [PDF]
Front PharmacolTorres de Souza G +6 more
europepmc +1 more source
Assessing the Efficacy of Multimodal Therapy in Nonsurgical Hair Restoration for Noncicatricial Alopecia: A Retrospective Study. [PDF]
Plast Reconstr Surg Glob OpenManakchand KK, Maheshwari S, Kumar A.
europepmc +1 more source
Mesotherapy with dutasteride in the treatment of androgenetic alopecia
International Journal of Trichology, 2017 Saceda-Corralo, David +3 more
openaire +3 more sources
Autologous Micrograft Technology (AMT) and Finasteride for the Management of Androgenic Alopecia - A Systematic Review and Meta-Analysis of Their Efficacy and Safety. [PDF]
Dermatol Pract ConceptEllerby A, Knudsen R.
europepmc +1 more source
Association between insulin resistance and prostate volume: A 4-year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. [PDF]
BJUI CompassDaniels JP +6 more
europepmc +1 more source
Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. [PDF]
Ann DermatolLee S +13 more
europepmc +1 more source